BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19071000)

  • 1. How age affects the biology of breast cancer.
    Thomas GA; Leonard RC
    Clin Oncol (R Coll Radiol); 2009 Mar; 21(2):81-5. PubMed ID: 19071000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
    Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
    J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and prognosis for molecular breast cancer subtypes in Chinese women.
    Zhao J; Liu H; Wang M; Gu L; Guo X; Gu F; Fu L
    J Surg Oncol; 2009 Aug; 100(2):89-94. PubMed ID: 19544363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy.
    Okunade G; Green AR; Ying M; Agrawal A; Paish EC; Aleskandrany M; Winterbottom L; Hassell K; Morgan DA; Ellis IO; Cheung KL
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):76-82. PubMed ID: 19515574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of cancer and aging.
    Balducci L
    J Oncol Manag; 2005; 14(2):47-50. PubMed ID: 16018199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia and cancer in older persons.
    Penninx BW; Cohen HJ; Woodman RC
    J Support Oncol; 2007 Mar; 5(3):107-13. PubMed ID: 17410807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer in Asia.
    Yip CH
    Methods Mol Biol; 2009; 471():51-64. PubMed ID: 19109774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.
    Kok M; Koornstra RH; Margarido TC; Fles R; Armstrong NJ; Linn SC; Van't Veer LJ; Weigelt B
    J Pathol; 2009 Jul; 218(3):316-26. PubMed ID: 19353633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of basal-like subtype in triple-negative breast cancer.
    Yamamoto Y; Ibusuki M; Nakano M; Kawasoe T; Hiki R; Iwase H
    Breast Cancer; 2009; 16(4):260-7. PubMed ID: 19701681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cancer survival gap between elderly and middle-aged patients in Europe is widening.
    Quaglia A; Tavilla A; Shack L; Brenner H; Janssen-Heijnen M; Allemani C; Colonna M; Grande E; Grosclaude P; Vercelli M;
    Eur J Cancer; 2009 Apr; 45(6):1006-16. PubMed ID: 19121578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
    Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
    Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status.
    Dent R; Hanna WM; Trudeau M; Rawlinson E; Sun P; Narod SA
    Cancer; 2009 Nov; 115(21):4917-23. PubMed ID: 19691094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological characteristics and prognosis of patients with breast cancer over 65 years of age].
    Gao JD; Zhang BN; Wang X; Wang J; Bi XF
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):83-6. PubMed ID: 19489267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy.
    Guarneri V; Conte P
    Oncologist; 2009 Jul; 14(7):645-56. PubMed ID: 19608638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and pathological characteristics and treatment of elderly patients with breast cancer].
    Ma CD; Chen XS; Liu GY
    Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1397-9. PubMed ID: 19094511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Worse prognosis for older breast cancer patients].
    van de Water W; Bastiaannet E; de Craen AJ; Westendorp RG; van de Velde CJ; Liefers GJ
    Ned Tijdschr Geneeskd; 2012; 156(33):A5074. PubMed ID: 22894809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer in Chinese elderly women: pathological and clinical characteristics and factors influencing treatment patterns.
    Ma CD; Zhou Q; Nie XQ; Liu GY; Di GH; Wu J; Lu JS; Yang WT; Chen JY; Shao ZM; Shen KW; Shen ZZ
    Crit Rev Oncol Hematol; 2009 Sep; 71(3):258-65. PubMed ID: 19150602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can sentinel node biopsy be avoided in some elderly breast cancer patients?
    Chagpar AB; McMasters KM; Edwards MJ;
    Ann Surg; 2009 Mar; 249(3):455-60. PubMed ID: 19247034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.